scholarly journals The temporal and long‐term impact of donor body mass index on recipient outcomes after kidney transplantation – a retrospective study

2019 ◽  
Vol 33 (1) ◽  
pp. 59-67 ◽  
Author(s):  
Abhijit S. Naik ◽  
Yingchao Zhong ◽  
Ravi Parasuraman ◽  
Mona Doshi ◽  
Silas Norman ◽  
...  
2015 ◽  
Vol 69 (11) ◽  
pp. 1357-1365 ◽  
Author(s):  
L. Orlic ◽  
I. Mikolasevic ◽  
I. Jakopcic ◽  
A. Grskovic ◽  
I. Jelic Pranjic ◽  
...  

2016 ◽  
Vol 21 ◽  
pp. 626-631 ◽  
Author(s):  
Ilona Kurnatowska ◽  
Aneta Małyska ◽  
Kamila Wysocka ◽  
Katarzyna Mazur ◽  
Joanna Krawczyk ◽  
...  

2012 ◽  
Vol 94 (10S) ◽  
pp. 270
Author(s):  
A. Weissenbacher ◽  
M. Jara ◽  
H. Ulmer ◽  
C. Bösmüller ◽  
S. Schneeberger ◽  
...  

2013 ◽  
Vol 15 (4) ◽  
pp. 463-469 ◽  
Author(s):  
Q. Denost ◽  
L. Quintane ◽  
E. Buscail ◽  
M. Martenot ◽  
C. Laurent ◽  
...  

2019 ◽  
Author(s):  
Adam Arshad ◽  
James Hodson ◽  
Khalid Khalil ◽  
Adnan Sharif

Abstract Background The aim of this study was to describe the changes in body mass index (BMI) after kidney transplantation and assess how this influences long-term outcomes. Methods Data were collected for all kidney transplant recipients between January 2007 and July 2016. Changes in BMI over the post-transplant period were modelled using a generalised estimating equation. The change in BMI from pre-transplantation to six months was then calculated for each patient. These were categorised into three groups: stable BMI (a change of ±1.5 kg/m2), BMI reduction and BMI increase (changes of >1.5 kg/m2), between which a range of outcomes were compared. Results Data was available for 1,344 patients, who had a geometric mean pre-transplant BMI of 27.3 kg/m2. This declined significantly (P<0.001), to a geometric mean of 25.6 kg/m2 one month after transplantation, before increasing and stabilising to pre-transplant levels by 36 months (geometric mean 27.2 kg/m2, P=0.522). The n=882 patients with BMI measurements at six months, were divided into groups of reduced (n=303), stable (n=388) and increased (n=131) BMI, relative to pre-transplantation levels. On multivariate analysis, 12-month creatinine levels were significantly higher in the BMI reduction cohort, with adjusted levels of 160.6 μmol/l, compared to 135.0 μmol/l in stable BMI. However, no significant associations were detected between six-month BMI change and patient survival, graft survival, incidence of post-transplant diabetes, cancer, or a range of clinical and histological outcomes (all P>0.05). Conclusions Our data demonstrates that BMI significantly reduces in the first month after kidney transplantation, before increasing to pre-transplant levels at 3-5 years. Furthermore, patients with decreasing BMI at six-months have impaired graft function in the long-term. These observations conflict with the existing literature and warrant further investigation.


2021 ◽  
Vol 15 (6) ◽  
pp. 1500-1502
Author(s):  
M. U. Marri ◽  
Z. Khan ◽  
A. A. Mufti ◽  
E. Gul ◽  
A. Kamal

Objective: To determine the frequency of complications after electroconvulsive treatment in patients with schizophrenia. Study Design: Retrospective study Place and Duration of Study: Department of Psychiatry, Balochistan Institute of Psychiatry & Behavioural Sciences, Quetta 1st August 2020 to 31st March 2021. Methodology: One hundred and twenty patients of both genders were presented in this study. Patients were aged between 20-70years. Patient’s detailed demographics age, sex and mean body mass index were recorded after taking informed written consent. Patients of schizophrenia received electroconvulsive treatment. Frequency of immediate complications was observed after each session of electroconvulsive treatment and at the end of electroconvulsive treatment frequency of long term complications were observed. Results: Sixty five (54.17%) were males and 55 (45.83%) were females with mean age were 40.14±3.45 years and mean body mass index 22.14±6.12 kg/m2. Mean electroconvulsive treatment sessions was 88.13±6.87. Mean hospitalization stay was 3.4±2.04 weeks. Frequency of immediate complications were 25 (20.83%) among patients after electroconvulsive treatment session. Among 20.83%, frequency of body aches was 7 (8.83%), headache was in 11 (9.17%), frequency of transient amnesia was among 3 (2.5%) and hypertension was among 4 (3.33%). Significantly no any delay complications were observed in continuously sessions among enrolled cases. Conclusion: The use of electroconvulsive treatment sessions in patients of schizophrenia was effective because no any delay complications were observed in this treatment. Keywords: Schizophrenia, Electroconvulsive treatment (ECT), Treatment sessions


Sign in / Sign up

Export Citation Format

Share Document